Lenvima and Peginterferon beta-1a

• Generic Name: lenvatinib
• Dosage Forms: capsule
• Other Brand Names: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose

Lenvima (lenvatinib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Lenvima is used to treat thyroid cancer. It is usually given after radioactive iodine has been tried without success.

Lenvima is used together with everolimus (Afinitor) to treat advanced kidney cancer when other medicines have not been effective.

Lenvima is used alone to treat liver cancer that cannot be removed with surgery.

Lenvima is used together with pembrolizumab (Keytruda) to treat a certain type of endometrial cancer (a type of uterine cancer) that has progressed and cannot be removed with surgery or radiation.

• Generic Name: peginterferon beta-1a
• Dosage Forms: n.a.
• Other Brand Names: Plegridy, Plegridy Pen, Plegridy Pen Starter Pack, Plegridy Starter Pack

Peginterferon beta-1a is used to treat relapsing multiple sclerosis (MS) in adults who are 18 to 65 years old.

peginterferon beta-1a will not cure MS, it will only decrease the frequency of relapse symptoms.

Peginterferon beta-1a may also be used for purposes not listed in this medication guide.